Vineet Agarwal sold $800k of KRRO
Chief Financial Officer at Korro Bio, Inc.. 10,216 shares at an average of $78.26, traded Oct 17, 2024, filed Oct 18, 2024.
Score components
- +22RoleCFO
- +22Trade size$800k at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -40.6%, 3m -53.8%, 6m -82.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-115723, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 17, 2024 | MOption exercise Common Stock10b5-1 | +9,263 | $11.68 | $108k | 9,263 | Oct 18, 2024 |
| Oct 17, 2024 | MOption exercise Common Stock10b5-1 | +953 | $14.98 | $14k | 10,216 | Oct 18, 2024 |
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -2,023 | $71.51 | $145k | 8,193 | Oct 18, 2024 |
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -164 | $73.71 | $12k | 8,029 | Oct 18, 2024 |
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -115 | $74.56 | $8,575 | 7,914 | Oct 18, 2024 |
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -56 | $76.00 | $4,256 | 7,858 | Oct 18, 2024 |
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -23 | $77.00 | $1,771 | 7,835 | Oct 18, 2024 |
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -260 | $77.55 | $20k | 7,575 | Oct 18, 2024 |
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -457 | $78.59 | $36k | 7,118 | Oct 18, 2024 |
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -1,815 | $79.79 | $145k | 5,303 | Oct 18, 2024 |
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -4,961 | $80.50 | $399k | 342 | Oct 18, 2024 |
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -317 | $81.48 | $26k | 25 | Oct 18, 2024 |
| Oct 17, 2024 | SOpen-market sale Common Stock10b5-1 | -25 | $82.89 | $2,072 | 0 | Oct 18, 2024 |
| Oct 17, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -9,263 | $0.00 | $0 | 31,607 | Oct 18, 2024 |
| Oct 17, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -953 | $0.00 | $0 | 45,594 | Oct 18, 2024 |
Related signals
Other insiders at Korro Bio, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 24Weak | Korro Bio, Inc. | Jean Francois Formela director | $686k 48,690 shares | -7% | |
| 3Weak | Korro Bio, Inc. | Oliver Dolan Senior Vice President, Finance | $69 5 shares | -0% | |
| 23Weak | Korro Bio, Inc. | Oliver Dolan Senior Vice President, Finance | $99k 7,353 shares | -31% | |
| 14Weak | Korro Bio, Inc. | Vineet Agarwal Chief Financial Officer | $56k 800 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.